CFM
RLAY icon

Cornerstone Financial Management’s Relay Therapeutics RLAY Stock Holding History

Cornerstone Financial Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03K Hold
162
– – ﹤0.01% 733
2026
Q1 		$1.61K Hold
162
– – ﹤0.01% 809
2025
Q4 		$1.37K Buy
+162
New +$1.16K ﹤0.01% 816

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Cornerstone Financial Management's RLAY Position: Q2 2026 in Review

Cornerstone Financial Management held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 162 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Cornerstone Financial Management first reported a position in RLAY in Q4 2025 and has held it in 3 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Cornerstone Financial Management held 162 shares of Relay Therapeutics worth $3.03K as of Q2 2026.
  • Cornerstone Financial Management left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #733 holding.
  • Cornerstone Financial Management first reported a position in Relay Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.